Magnetar Financial’s iRadimed IRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$334K Buy
+3,499
New +$319K ﹤0.01% 735
2025
Q3
Sell
-10,330
Closed -$618K 1029
2025
Q2
$618K Sell
10,330
-1,517
-13% -$83.1K ﹤0.01% 519
2025
Q1
$622K Buy
11,847
+645
+6% +$36.2K 0.01% 418
2024
Q4
$616K Buy
11,202
+6,312
+129% +$332K 0.01% 341
2024
Q3
$246K Sell
4,890
-1,576
-24% -$72.7K 0.01% 435
2024
Q2
$284K Buy
+6,466
New +$275K 0.01% 393

Other funds holding IRMD

Magnetar Financial's IRMD Position: Q2 2026 in Review

Magnetar Financial opened a new position in iRadimed (IRMD) in Q2 2026: 3,499 shares worth $334K. The stake represents ﹤0.01% of the portfolio and ranks #735 among its holdings. This is a return to the name: Magnetar Financial previously reported a position in IRMD as recently as Q2 2025.

Magnetar Financial first reported a position in IRMD in Q2 2024 and has held it in 6 quarters since. The position peaked at $622K in Q1 2025. 214 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

  • Magnetar Financial held 3,499 shares of iRadimed worth $334K as of Q2 2026.
  • iRadimed was a new Magnetar Financial position in Q2 2026.
  • iRadimed made up ﹤0.01% of Magnetar Financial's portfolio in Q2 2026, its #735 holding.
  • Magnetar Financial first reported a position in iRadimed in Q2 2024 and has held it in 6 quarters since.
  • Magnetar Financial's iRadimed position peaked at $622K in Q1 2025.
  • 214 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on Magnetar Financial's 13F filing for Q2 2026, filed 14 Aug 2026.